Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Cipla
Federal Trade Commission
McKesson
Chubb
Moodys
US Army
Merck

Generated: December 14, 2018

DrugPatentWatch Database Preview

PREVACID Drug Profile

« Back to Dashboard

Which patents cover Prevacid, and what generic alternatives are available?

Prevacid is a drug marketed by Takeda Pharms Usa, Takeda Pharms Na, and Glaxosmithkline Cons. and is included in six NDAs. There are six patents protecting this drug and two Paragraph IV challenges.

This drug has sixty-six patent family members in nineteen countries.

The generic ingredient in PREVACID is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.

Drug patent expirations by year for PREVACID
Pharmacology for PREVACID
Synonyms for PREVACID
(+)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
103577-45-3
1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-
1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
2-?[[[3-?METHYL-?4-?(2,?2,?2-?TRIFLUOROETHOXY)-?2-?PYRIDINYL]METHYL]SULFINYL]-?1H-?BENZIMIDAZOLE
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfinyl)benzimidazol e
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole;2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[ [3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl]methyl]-sulfinyl]1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylsulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole
2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzimidazole
2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole
2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl]-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl]-1H-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl]-1H-benzimidazole
2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole
2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl}-1H-benzimidazole
577L453
A 65006
A-65006
A800764
AB0005100
AB00052388
AB00052388_18
AB00052388_19
AB00052388-17
AB2000063
Abbot Brand of Lansoprazole
ABT-006
AC1L1GX8
ACT03358
AG 1749
AG-1749
Agopton
Agopton (TN)
AKOS005554811
Almirall Brand of Lansoprazole
AN-15125
API0005388
Aprazol
Bamalite
BBL029072
BC208317
BDBM47032
BDBM50070208
BG0232
BIDD:GT0006
Bio-0824
Biuret Gr
Biuret Reagent Solution
Blason
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
C-21097
C16H14F3N3O2S
CAS-103577-45-3
CC-29843
CCG-39952
CG-4801
CHEBI:6375
CHEMBL480
cid_3883
CL0035
Compraz
CPD000058469
CS-1847
CTK8F0500
D00355
D0M4HV
Dakar
DB00448
DivK1c_000920
DR002018
DSSTox_CID_3200
DSSTox_GSID_23200
DSSTox_RID_76922
DTXSID4023200
EBD14854
EU-0100709
F2173-0222
FT-0082011
FT-0610894
GP5308
GTPL7208
HE130807
HE291353
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS2098G06
HMS2234B10
HMS3262M19
HMS3264E12
HMS3269D15
HMS3371E21
HMS3394F05
HMS3654J17
HMS502N22
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
HSDB 7204
HY-13662
I06-0018
IDI1_000920
Ilsatec
J-007154
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
KS-00000VHO
L 8533
L0233
Lancid
Lanfast
Lanproton
LANSAPRAZOLE
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole (JP17/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard
Lansoprazole, >=98% (TLC), powder
Lansoprazole, 98% 500mg
Lansoprazole, British Pharmacopoeia (BP) Reference Standard
Lansoprazole, European Pharmacopoeia (EP) Reference Standard
Lansoprazole, United States Pharmacopeia (USP) Reference Standard
Lansoprazole.
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lansox (TN)
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
lanzoprazole
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Lopac-L-8533
Lopac0_000709
LP00709
LS-33080
MCULE-8446262134
Mesactol
MFCD00866873
MJIHNNLFOKEZEW-UHFFFAOYSA-N
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
MLS001424235
MolPort-003-666-508
Monolitum
NC00411
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-04
NCGC00015615-05
NCGC00015615-06
NCGC00015615-07
NCGC00015615-08
NCGC00015615-09
NCGC00015615-10
NCGC00015615-11
NCGC00015615-12
NCGC00015615-14
NCGC00015615-15
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NCGC00254925-01
NCGC00261394-01
NINDS_000920
NSC-758638
NSC-758710
NSC758638
NSC758710
Ogast
Ogast (TN)
Ogastro
Opera_ID_1676
Opiren
Pharmakon1600-01503926
Pharmakon1600-01504282
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
Prevacid (TN)
Prevacid 24HR
Prevacid Delayed Release
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid NapraPAC
Prevacid SoluTab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevacid;Prevacid NapraPAC;Prevacid SoluTab
PrevOnco
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
PubChem16834
RT-013461
s1354
Salvar Brand of Lansoprazole
SAM001246544
SBI-0050687.P003
SC-15158
SCHEMBL22365
SMR000058469
SPBio_000488
SPBio_002992
Spectrum_001580
SPECTRUM1503926
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
ST51015040
STK621169
Suprecid
TAK 390MR
TAK390MR
Takeda Brand of Lansoprazole
Takepron
Takepron (TN)
TAP Brand of Lansoprazole
Tecnobio Brand of Lansoprazole
TL8000155
Tox21_110184
Tox21_110184_1
Tox21_301023
Tox21_500709
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton

US Patents and Regulatory Information for PREVACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa PREVACID lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 020406-001 May 10, 1995 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID NAPRAPAC 375 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-003 Nov 14, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa PREVACID lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 021428-001 Aug 30, 2002 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-002 May 3, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa PREVACID lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 021428-002 Aug 30, 2002 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Takeda Pharms Usa PREVACID lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 021428-001 Aug 30, 2002 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for PREVACID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa PREVACID lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 020406-001 May 10, 1995 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa PREVACID lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 021428-002 Aug 30, 2002 ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa PREVACID lansoprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 021428-001 Aug 30, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for PREVACID
Drugname Dosage Strength RLD Date
➤ Subscribe Delayed-release Orally Disinte 15 mg and 30 mg ➤ Subscribe ➤ Sign Up
➤ Subscribe Delayed-release Pellets/Capsul 15 mg and 30 mg ➤ Subscribe ➤ Sign Up

Supplementary Protection Certificates for PREVACID

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
14/008 Ireland ➤ Sign Up PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
C0021 Belgium ➤ Sign Up PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0021 Belgium ➤ Sign Up PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Deloitte
McKesson
Daiichi Sankyo
UBS
Dow
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.